©TumorGen 2019, All Rights Reserved

  • Facebook Social Icon
  • Twitter Social Icon

Leadership Team

Jeffrey K. Allen, Ph.D.

Peter Teriete, D. Phil.

Leeann Bare

Founder, President & CEO 

CSO & Co-Founder

Commercial Strategy &

Partnership Development

Dr. Jeff Allen has over 20 years of experience in biotechnology, analyzing complex biological problems and then combining new and existing technologies to create innovative solutions. Throughout his career at Beckman (Coulter), Gen-Probe (Hologic) and BD,  Jeff has utilized both technical and business skill sets to launch new molecular based systems. The same combination of skills sets is now being applied to help find a cure for cancer. Dr. Allen has assembled a team of exceptional scientists with expertise in many different areas and given them a single focus; identify and capture cancer stem cells, The Root Cause of Cancer.

Dr. Teriete is a Research Assistant Professor  at the NCI-designated Cancer Center at SBP. He received his D.Phil. in biophysics and biochemistry from the University of Oxford, United Kingdom, in 2004. Dr. Teriete was the lead scientist in solving the solution structure of the hyaluronan binding domain of the leukocyte homing receptor CD44. Dr. Teriete has published over 30 peer-reviewed research articles investigating relevant proteins for structure determination efforts, their role as bio-markers for prognosis in cancer, and as target to develop novel and potent therapeutics. Dr. Teriete has always explored entrepreneurial interest and completed a business certificate in Science Entrepreneurship from the Saïd Business School, University of Oxford.

Leeann Bare is an experienced executive with an innate ability to assess new biotechnology developments, including regulatory require-ments and devise optimized growth strategies for successful product launches.  Her experience at Caris Life Sciences, which provides comprehensive tumor profiling as well as biopharmaceutical research contract services in addition to her established connections with C-suite biomedical executives, is an ideal background for developing and implementing our growth strategy.

 

Scientific & Medical Advisory Board

Ezra Cohen, MD

Associate Director, Professor of Medicine

Moores Cancer Center, UC San Diego

Gaelle.png

Gaëlle Rondeau, Ph.D.

Senior Research Scientist

Vaccine Research Institute of San Diego 

Samuel K. Kassegne, Ph.D., PE

Associate Professor, Director of MEMS Research Lab
Department of Mechanical Engineering, SDSU

Gregory Botta, MD, Ph.D.

Oncology Physician Scientist

Scripps MD Anderson Cancer Center

Leslie Crews, Ph.D.

Assistant Adjunct Professor

University of California, San Diego

Nicholas D.P. Cosford, Ph.D.

Professor and Associate Director of Translational Research

NCI-Designated Cancer Center,

SBP Medical Discovery Institute, La Jolla